430 Participants Needed

Telehealth for Childhood Asthma

(TEACH-ER Trial)

Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Rochester
Must be taking: Daily controller
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new method for caring for children with asthma after an emergency room visit. The study compares two approaches: one group receives enhanced standard care (Enhanced Care, EC), while the other receives additional support through telehealth visits and specialized education on managing asthma at home (Telehealth-Enhanced Asthma Care for Home After the Emergency Room, TEACH-ER). The researchers aim to determine if telehealth can reduce the need for further emergency visits, improve asthma symptoms, and enhance the quality of life for children. Children aged 3 to 12 who recently visited the emergency room for asthma and live in Monroe County, NY, may be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to innovative asthma care strategies that could improve children's health and well-being.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications. It seems likely that participants will continue their current asthma medications, as the study focuses on enhancing asthma care.

What prior data suggests that this telehealth approach is safe for childhood asthma care?

Research has shown that telehealth for children with asthma is generally safe and effective. Studies have found that telemedicine helps children adhere to their treatment plans and improves their quality of life while reducing unexpected emergency room visits.

No serious side effects have been reported in studies on telehealth for asthma care. Regular online check-ins enable children to manage their asthma better. This method educates families about asthma and ensures correct medication use, with no major safety issues identified.

In summary, telehealth for asthma management appears to be a safe choice for children, aiding in asthma control without introducing new risks.12345

Why are researchers excited about this trial?

Researchers are excited about Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER) because it offers a new way to manage childhood asthma using telehealth technology right after an emergency room visit. Unlike traditional asthma care, which typically involves in-person follow-ups and standard medication management, TEACH-ER integrates virtual check-ins and personalized care plans, making it easier for families to manage asthma symptoms at home. This approach not only aims to reduce the need for repeat hospital visits but also empowers parents and children with real-time support and guidance from healthcare professionals. By leveraging technology, TEACH-ER could significantly improve asthma management and overall quality of life for children with asthma.

What evidence suggests that this trial's treatments could be effective for childhood asthma?

Research shows that telehealth can improve asthma management after an emergency room visit. In this trial, participants in the Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER) arm will receive a new model of patient-centered asthma management. Studies on similar telehealth programs have found that children experienced better asthma control and missed fewer school days. For instance, children using telehealth had an average of 1.32 more symptom-free days and were less likely to need another emergency visit. This evidence suggests that telehealth can help maintain asthma control and reduce hospital visits. Meanwhile, participants in the Enhanced Care (EC) Comparison Group will receive standard emergency department care for asthma exacerbations, enhanced through a report of recent symptoms sent to PCPs and systematic feedback on asthma management.12467

Are You a Good Fit for This Trial?

This trial is for children aged 3-12 with persistent asthma or poor control, living in Monroe County, NY. They must have had an emergency visit for acute asthma and be on a daily controller medication as per NHLBI guidelines. Excluded are those who can't understand English or Spanish, lack phone access, are in foster care without guardian consent, or have other significant medical conditions.

Inclusion Criteria

Child and caregiver live in Monroe County, NY
My child is between 3 and 12 years old.
I have asthma that requires daily medication.
See 2 more

Exclusion Criteria

I do not have major health issues like cystic fibrosis or serious heart disease that could affect asthma assessments.
No access to a working phone for follow-up surveys
Children in foster care or other situations in which consent cannot be obtained from a legal guardian
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Initial Education and Discharge

Brief, pictorial, and health literacy-informed asthma education in the ED, with color- and shape-coded labels provided for home asthma medications

1 day
1 visit (in-person)

Telehealth Follow-up

Virtual primary care follow-up within 1 week of discharge using in-home telemedicine, featuring provider prompts for guideline-based preventive therapy and home delivery of prescribed medications with pictorial action plans

1 week
1 visit (virtual)

Continued Virtual Visits

Two additional in-home virtual visits to reinforce teaching, review treatment plans, label medications, and support effective management practices

2 weeks
2 visits (virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment through blinded follow-up telephone surveys at 3, 6, 9, and 12 months after discharge

12 months
4 visits (telephone)

What Are the Treatments Tested in This Trial?

Interventions

  • Enhanced Care (EC)
  • Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER)
Trial Overview The study compares TEACH-ER—a telehealth program including education in the ER, virtual follow-ups with home medication delivery—and Enhanced Care (EC). It aims to see if TEACH-ER reduces further emergency visits/hospitalizations over a year and improves symptoms, adherence to medication, quality of life and guideline-based care.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Telehealth-Enhanced Asthma Care for Home After the Emergency RoomExperimental Treatment1 Intervention
Group II: Enhanced Care (EC) Comparison GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Rochester

Lead Sponsor

Trials
883
Recruited
555,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Published Research Related to This Trial

The study involved 10 pediatric patients with persistent asthma who used an Internet-based telehealth system to monitor their medication adherence and asthma control, showing significant improvement in inhaler technique scores during the second study period.
Caregivers reported improved quality of life for patients in the virtual education group, and the telehealth system effectively reduced emergency department visits and hospital admissions, indicating its efficacy and acceptance among users.
An Internet-based store-and-forward video home telehealth system for improving asthma outcomes in children.Chan, DS., Callahan, CW., Sheets, SJ., et al.[2019]
Telemedicine in school settings for asthma education showed positive or neutral effects on quality of life and self-management behaviors for children, with no reported negative effects from the interventions.
Clinical outcomes related to asthma management, such as airway inflammation and medication use, had mixed results, indicating that while some improvements were noted, further validation of these telemedicine methods is needed.
Telemedical Asthma Education and Health Care Outcomes for School-Age Children: A Systematic Review.Culmer, N., Smith, T., Stager, C., et al.[2021]
A tailored self-management intervention delivered in the pediatric emergency department significantly increased caregivers' confidence in managing their child's asthma 14 days after the intervention.
The intervention group had more well-asthma visits and fewer urgent care or emergency department visits at 9 months, particularly among children with intermittent asthma, indicating potential long-term benefits of the program.
Delivering tailored asthma family education in a pediatric emergency department setting: a pilot study.Sockrider, MM., Abramson, S., Brooks, E., et al.[2019]

Citations

Telehealth-Enhanced Asthma Care for Home after the ...The TEACH-ER intervention combines and expands upon our prior work, and includes: 1) brief initial teaching in the ED; 2) in-home telehealth follow-up visit ...
NCT03414177 | Telehealth Enhanced Asthma ManagementThe overarching hypothesis is that utilization of TM for asthma follow-up will result in improved clinical outcomes such as Asthma Control Test (ACT) scores, ...
Effect of the Telemedicine Enhanced Asthma Management ...TEAM-ED significantly improved follow-up and preventive care after an ED visit for asthma. We also saw improved SFDs with pre-pandemic data.
Effect of the Telemedicine Enhanced Asthma Management ...We found that children in TEAM-UP vs eUC had more SFDs (mean difference: 1.32; 95% CI 0.58–2.05) and were less likely to miss school (OR: 0.70; ...
Effect of the Telemedicine Enhanced Asthma Management ...This intervention was designed to decrease asthma morbidity by improving the delivery of preventive asthma care after an emergency visit for asthma.
Telehealth for Childhood Asthma (TEACH-ER Trial)The investigators propose a randomized controlled trial of Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER) vs. enhanced care (EC).
A telemedicine care protocol for pediatric and adolescent ...Telemedicine significantly enhances asthma management, improving treatment adherence, quality of life, and patient education while reducing unplanned visits.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security